CPT code 69930 denotes surgical implantation of a cochlear implant system, a procedure that places an internal receiver-stimulator and electrode array beneath the skin and secures them in bone, with external components (microphone, speech processor, transmitter) fitted externally. The surgery typically abolishes residual natural hearing in the implanted ear and is most often performed unilaterally. This code captures a high-impact intervention for severe-to-profound sensorineural hearing loss and is central to specialty otologic surgical billing and coverage policy nationwide.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical sites of service (operating room in inpatient or outpatient surgical settings), common billing considerations, and the payer landscape that influences prior authorization and coverage criteria. The publication outlines benchmarks for utilization and reimbursement coding practice, summarizes relevant policy updates affecting access to cochlear implantation, and provides clinical context on patient selection and implications for residual hearing. Data not available in the input is noted where applicable. The content is intended for billing managers, otolaryngology clinicians, and policy analysts seeking a national-level reference on coding and coverage considerations for cochlear implant surgery under CPT code 69930.